We are live on ! Find out more
HUMAW

Humacyte Inc Warrant
HUMAW

Delisted

HUMAW was delisted on the 25th of August, 2026.

Back to rankings

12 hedge funds and large institutions have $1.58M invested in Humacyte Inc Warrant in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 15 → 12 (-3)

32% less capital invested

Capital invested by funds: $2.33M → $1.58M (-$748K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
4
Closed
4
Calls
$583K
Puts
–
Net Calls
+$583K
Net Calls Change
-$99K

Top Buyers

Rank Fund Capital Flow
1
RL
RPO LLC
Connecticut
+$138K

Top Sellers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
-$342K
2
ICM
Ionic Capital Management
New York
-$229K
3
CH
CVI Holdings
Delaware
-$38.3K
4
ICMH
Integrity Capital Management (HK)
Hong Kong
-$36K
5
VF
Virtu Financial
New York
-$24K

HUMAW Hedge Fund Activity: Q1 2022 in Review

12 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q1 2022, worth a combined $1.58M — down 32% from $2.33M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of HUMAW and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was RPO LLC, opening a new position worth an estimated $138K. The largest seller was LPL Financial, exiting entirely with an estimated $342K sold.

  • 12 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q1 2022, down from 15 in Q4 2021.
  • Funds reported $1.58M of Humacyte Inc Warrant stock for Q1 2022, down 32% quarter-over-quarter.
  • 1 fund opened new Humacyte Inc Warrant positions in Q1 2022 and 4 closed out, a net change of -3 holders.
  • The largest Humacyte Inc Warrant buyer in Q1 2022 was RPO LLC, an estimated $138K added.
  • The largest Humacyte Inc Warrant seller in Q1 2022 was LPL Financial, an estimated $342K sold.

Based on aggregated 13F filings for Q1 2022.